Pakistan Journal of Pharmaceutical Sciences
Author: Lala Rukh, Halima Nazar and Khan Usmanghani Publishing Date: 2016 E-ISSN: 1011-601X Volume 29 Issue 6 ABSTRACT: Nausea and vomiting is the common problem disturbing almost 80% of the females in initial three months of conception and later sometime throughout pregnancy. To find out the efficacy and safety of herbal coded test drug Gingocap in comparison with the control drug […]
Author: Shadab Ahmed, Rafeeq Alam Khan and Subia Jamil Publishing Date: 2016 E-ISSN: 1011-601X Volume 29 Issue 6 ABSTRACT: Diet rich in saturated fats and sugars have been associated with obesity, insulin resistance, hyperlipidemia and fatty liver disease. Especially high serum lipid levels are directly connected to the progression of cardiovascular disorders, which are the leading cause of death all over
Author: Baâtour Olfa1, Aouadi Mariem, Abbassi Mohamed Salah and Ben Nasri Ayachi Mouhiba Publishing Date: 2016 E-ISSN: 1011-601X Volume 29 Issue 6 ABSTRACT: Essential oils of marjoram were extracted from plants, growing under non-saline and saline condition (75mM NaCl). Their antioxidant and antibaterial activity againt six bacteria (Enterococcus faecalis, Escherichia coli, Salmonella enteritidis, Listeria ivanovii, Listeria inocula, and Listeria monocytogenes) were
Author: Atif Abbasi, Muhammad Rafique, Amir Saghir, Kamran Abbas, Shabnum Shaheen and Farooq Abdullah Publishing Date: 2016 E-ISSN: 1011-601X Volume 29 Issue 6 ABSTRACT: To assess the awareness about the spread and control of tuberculosis as well as to investigate the gender and occupation wise differences among people regarding knowledge and attitude towards tuberculosis in the State of AJ & K.
Author: Abeer Mahmoud Badr Publishing Date: 2016 E-ISSN: 1011-601X Volume 29 Issue 6 ABSTRACT: Interleukin (IL)-6 can induce matrix metalloproteinases (MMPs) expression, which may be critical factors involved in tumor metastasis. Tissue inhibitors of metalloproteinases (TIMPs) are important inhibitory enzymes of MMP. This study was designed to investigate the effect of recombinant IL-6 on the MMP/TIMP expression in MDA-MB-231 breast cancer